P025 MAINTENANCE Q8 THERAPY OF CROHN'S DISEASE WITH INFLIXIMAB IS ASSOCIATED WITH ENDOSCOPIC MUCOSAL HEALING IN THE LONG-TERM
β Scribed by F. Schnitzler; H. Fidder; M. Ferrante; M. Noman; G. Van Assche; I. Hoffman; S. Vermeire; P. Rutgeerts
- Book ID
- 119637223
- Publisher
- Oxford University Press
- Year
- 2008
- Weight
- 70 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1873-9954
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients
Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i